Carlos Ferrándiz

Suggest Changes
Learn More
BACKGROUND Apremilast, an oral phosphodiesterase 4 inhibitor, regulates immune responses associated with psoriasis. OBJECTIVES ESTEEM 2 evaluated the efficacy and safety of apremilast 30 mg twice(More)